Novavax (NVAX) Misses Q2 EPS by 4c
Get Alerts NVAX Hot Sheet
Price: $4.13 -1.43%
Revenue Growth %: +85.7%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Revenue Growth %: +85.7%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $8.03 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Fortive (FTV) Tops Q1 EPS by 4c ; Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!